Kimberly-Clark and Kenvue shareholders approve acquisition deal

Shareholders of Kimberly-Clark Corporation (NASDAQ: KMB) and Kenvue Inc. (NYSE: KVUE) voted to approve all proposals necessary for Kimberly-Clark's acquisition of Kenvue at special meetings held January 29.

Approximately 96% of shares present at Kimberly-Clark's special meeting voted to approve the issuance of Kimberly-Clark common stock in connection with the transaction, according to preliminary voting results. At Kenvue's meeting, approximately 99% of shares voted to adopt the merger agreement, representing about 77% of all outstanding shares.

"We are grateful to Kimberly-Clark shareholders who voted resoundingly in support of our combination with Kenvue," said Mike Hsu, Kimberly-Clark Chairman and Chief Executive Officer.

Kirk Perry, Chief Executive Officer of Kenvue, said the company thanks shareholders for their support in approving the transaction with Kimberly-Clark.

The transaction is expected to close in the second half of 2026, subject to regulatory approvals and other customary closing conditions. Final vote results will be filed with the U.S. Securities and Exchange Commission in separate Current Reports on Form 8-K.

Kimberly-Clark operates in more than 175 countries with brands including Huggies, Kleenex, Scott, Kotex, and Cottonelle. Kenvue, described as the world's largest pure-play consumer health company by revenue, owns brands including Aveeno, Band-Aid, Johnson's, Listerine, Neutrogena and Tylenol.

You May Also Be Interested In

• AES stockholders approve $10.7 billion takeover by GIP and EQT
• SEGG Media sues short seller for $20M over stock report
• Neuphoria confirms acquisition talks with Scancell Holdings